FDA Advisory Committee to Consider Tofersen…

This week Jeremy talks to Dr. Neil Thakur about The ALS Association’s comments to the FDA urging them to approve tofersen, a gene therapy targeting SOD1 mutations. He then digs into the tofersen clinical trials with lead investigator Dr. Timothy Miller. For more information on genetic testing and counseling go to https://www.als.org/understanding-als/who-gets-als/genetic-testingThis episode is brought to you by The ALS Association in partnership with CitizenRacecar.